CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us

  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Centrient Pharmaceuticals

Line Sandberg, Chief Quality Officer

Enhancing Compliance Through Process Leadership

Line Sandberg

Line Sandberg

Pharma Governance Advisor

Pharma businesses are becoming more and more complex. The number of partnerships, mergers and acquisitions are growing and the use of virtual supply chains is increasing. These developments require a much stronger and more aligned global approach to good practice (GxP) quality compliance.


A global company that operates in various continents, using both internal and external supply chains and selling products in both large, developed economies as well as emerging markets is very complex to manage from a GxP point of view. Such a company is at risk of the quality management system becoming misaligned and fragmented and may damage the company’s reputation with regulators and customers.


Process leadership is a very strong tool to secure efficient, compliant, and globally aligned processes regardless of locations and markets. With a quality management system built on the principles of process leadership, the standard operating procedure (SOP) hierarchy is built horizontally without dependencies on organizational structures. This means that if the organization changes its structure or goes through merger and acquisition activities, the key quality processes are sustained and remain controlled.


As an example, a process like “deviation investigation and corrective and preventive actions (CAPA) management” applies to the entire company and is not linked to any specific function or department. The process should therefore be managed by a process lead and a cross-functional process team. In that way, the process is globally aligned, and the process lead has the mandate to ensure that the process is continually reviewed and actively optimized and maintained.


When introducing process leadership, one should first develop the “process landscape” of the company. The process landscape is a map of all key processes in the company. Typically, the landscape will be built with three layers: management processes, core processes and supporting processes. Management processes could include for example organizational development, financial planning, and quality management review. Core processes would typically entail product development, life cycle management, sourcing, production, supply and post market surveillance. Supporting processes could be quality assurance, legal processes, human resource processes and others.


Navigating the company’s quality management system from the process landscape and not by departments or functions, educates the organization to apply process and enterprise thinking rather than promoting silo thinking and local suboptimization. It helps the company to become globally aligned with a strong governance structure.


"When introducing process leadership, one should first develop the ‘process landscape’ of the company"


When appointing process leads and process teams, the accountability, mandate, and responsibility become clear. With a stronger process governance, redundant and localized SOPs are avoided, and the quality management system can be kept lean and simple. Such a lean and simple quality management system that is easy to navigate ensures strong compliance and adherence to standards.


In order to emphasize the importance of process thinking, it is important that the roles of process leads and the existence of the process groups are formalized. Process lead roles must be documented in job descriptions and the development of the processes should be rewarded through the company’s performance management system. This brings clear benefits: focus is maintained and the incentive structure supports process thinking company-wide.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

For life sciences readers, global pharmaceutical quality now depends on process discipline that can withstand complex supply chains, partnerships and organizational change. Line Sandberg’s perspective matters because compliance is no longer a local function, but a shared operating responsibility across markets, teams and regulatory expectations.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesrevieweurope.com/leadership-perspective/line-sandberg-nwid-2299.html